The Michael J. Fox Foundation Parkinson's Podcast - Podcast: Dave Iverson & Dr. Todd Sherer: New Approaches to Treating Dyskinesia

Podcast: Dave Iverson & Dr. Todd Sherer: New Approaches to Treating Dyskinesia

02/07/12 • -1 min

The Michael J. Fox Foundation Parkinson's Podcast

Dyskinesia refers to the excessive and uncontrollable movements that are a side effect of long-term dopamine replacement therapy in patients with Parkinson's disease (PD).

Previous Episode

Podcast: Teva Seeks Label Change for Azilect

This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”

Next Episode

Podcast: What is the Connection Between Genetics and Environment in Parkinson's?

Understanding the genetics of Parkinson’s disease could be a game changer in developing new treatments for the disease. Especially when it comes to two genetic targets: LRRK2 and alpha-synuclein.